The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 01, 2018

Filed:

Jan. 31, 2013
Applicants:

Csl Behring Gmbh, Marburg, DE;

Csl Ltd., Parkville, Victoria, AU;

Julius-maximilians-universitaet-wuerzburg, Wuerzburg, DE;

Westfaelische Wilhelms-universitaet Muenster, Muenster, DE;

Inventors:

Sven Meuth, Muenster, DE;

Kerstin Goebel, Pfaffenhausen, DE;

Christoph Kleinschnitz, Hettstadt, DE;

Brent McKenzie, San Mateo, CA (US);

Marc Nolte, Marburg, DE;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61K 38/48 (2006.01); A61K 39/395 (2006.01); C07K 16/40 (2006.01); A61K 38/06 (2006.01); A61K 38/55 (2006.01); A61K 38/57 (2006.01); C07K 14/81 (2006.01); C07K 16/36 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); A61K 38/06 (2013.01); A61K 38/16 (2013.01); A61K 38/1774 (2013.01); A61K 38/48 (2013.01); A61K 38/4846 (2013.01); A61K 38/55 (2013.01); A61K 38/556 (2013.01); A61K 38/57 (2013.01); A61K 39/395 (2013.01); C07K 14/811 (2013.01); C07K 16/36 (2013.01); A61K 2039/505 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2319/30 (2013.01);
Abstract

This application relates to neurological inflammatory diseases, such as multiple sclerosis, and to methods of administering a Factor XII inhibitor to prevent, treat, or otherwise ameliorate the effects of a neurological inflammatory disease, such as multiple sclerosis. Agents and pharmaceutical compositions comprising agents which inhibit the activity of FXII are also provided.


Find Patent Forward Citations

Loading…